BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3607741)

  • 1. Use of DNA image cytometry in addition to flow cytometry for the study of patients with advanced ovarian cancer.
    Rodenburg CJ; Ploem-Zaaijer JJ; Cornelisse CJ; Mesker WE; Hermans J; Heintz PA; Ploem JS; Fleuren GJ
    Cancer Res; 1987 Aug; 47(15):3938-41. PubMed ID: 3607741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
    Hedley DW; Friedlander ML; Taylor IW
    Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma.
    Klapperstück T; Wohlrab W
    Cytometry; 1996 Sep; 25(1):82-9. PubMed ID: 8875057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures.
    Spyratos F; Briffod M
    Mod Pathol; 1997 Jun; 10(6):556-63. PubMed ID: 9195572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA image cytometry on machine-selected breast cancer cells and a comparison between flow cytometry and scanning cytophotometry.
    Cornelisse CJ; Van Driel-Kulker AM
    Cytometry; 1985 Sep; 6(5):471-7. PubMed ID: 4042787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
    Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
    Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA cytometry using paraffin embedded tumor tissues. Comparison of flow cytometry (FCM) and image cytometry (ICM)].
    Baretton G; Blasenbreu S; Li X; DePascale T; Löhrs U
    Zentralbl Pathol; 1994 Feb; 139(6):419-25. PubMed ID: 7512820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of flow and image DNA cytometry in prediction of patient prognosis in surgically resected small cell lung cancer.
    Carey FA; Gray E; O'Mahony M; Craig SR; Salto-Tellez M; Lamb D
    Anal Cell Pathol; 1996 Dec; 12(3):137-43. PubMed ID: 9025990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
    Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
    Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
    Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
    Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of image (CAS 200) and flow cytometry determined DNA content of paraffin-embedded Hodgkin's disease tissue.
    Erdkamp FL; Schouten HC; Breed WP; Janssen WC; Hoffmann JJ; Reynders M; Schutte B; Blijham GH
    Hematol Pathol; 1994; 8(3):75-84. PubMed ID: 7982854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
    Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ
    Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.